Your Article Summary
Prasugrel: The newest platelet inhibitor has arrived
American Pharmacists Association, 08/06/09
Clinical data show that the recently approved prasugrel is more effective than clopidogrel in reducing cardiovascular events in acute coronary patients who undergo percutaneous coronary intervention; however, the new drug is associated with a higher risk of major bleeding.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09
Recombinant Human Erythropoietin, Epogin Injection
Application for Approval of Additional Indication of Chemotherapy-Induced Anemia
Chugai Pharmaceutical Co., 12/08/09
Synthon announces European approvals for Raloxifene
Synthon, 12/08/09
Article Search
Sponsor


See Latest Articles


